Tectorigenin sodium sulfonate is primarily used for its pharmacological properties, particularly in cardiovascular and anti-inflammatory applications. It exhibits strong antioxidant effects, helping to reduce oxidative stress in tissues. This compound is investigated for its ability to protect heart function by improving myocardial energy metabolism and reducing damage during ischemia-reperfusion injury. It also shows potential in managing arrhythmias due to its influence on ion channels in cardiac cells. In addition, tectorigenin sodium sulfonate has been studied for its neuroprotective effects, where it may help mitigate brain injury following stroke by inhibiting inflammatory pathways and apoptosis. Its water solubility, enhanced by the sulfonate group, makes it suitable for intravenous formulations in clinical settings. It is used in some traditional medicine-derived preparations, especially in East Asia, for treating cerebrovascular and coronary diseases. Ongoing research explores its role in diabetes management and liver protection due to its metabolic regulatory effects.